CIBC Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $394K | Sell |
|
|||||
|
2025
Q1 | $474K | Buy |
|
|||||
|
2024
Q4 | $557K | Buy |
|
|||||
|
2024
Q3 | $414K | Buy |
|
|||||
|
2024
Q2 | $468K | Buy |
|
|||||
|
2024
Q1 | $448K | Buy |
|
|||||
|
2023
Q4 | $427K | Sell |
|
|||||
|
2023
Q3 | $390K | Buy |
|
|||||
|
2023
Q2 | $323K | Buy |
|
|||||
|
2023
Q1 | $346K | Buy |
|
|||||
|
2022
Q4 | $369K | Sell |
|
|||||
|
2022
Q3 | $452K | Buy |
|
|||||
|
2022
Q2 | $414K | Sell |
|
|||||
|
2022
Q1 | $403K | Buy |
|
|||||
|
2021
Q4 | $364K | Buy |
|
|||||
|
2021
Q3 | $370K | Buy |
|
|||||
|
2021
Q2 | $342K | Buy |
|
|||||
|
2021
Q1 | $342K | Sell |
|
|||||
|
2020
Q4 | $1.36M | Buy |
|
|||||
|
2020
Q3 | $1.29M | Buy |
|
|||||
|
2020
Q2 | $412K | Hold |
|
|||||
|
2020
Q1 | $292K | Hold |
|
|||||
|
2019
Q4 | $363K | Buy |
|
|||||
|
2019
Q3 | $287K | Hold |
|
|||||
|
2019
Q2 | $269K | Hold |
|
|||||
|
2019
Q1 | $280K | Hold |
|
|||||
|
2018
Q4 | $227K | Hold |
|
|||||
|
2018
Q3 | $391K | Hold |
|
|||||
|
2018
Q2 | $313K | Buy |
|
|||||
|
2018
Q1 | $246K | Hold |
|
|||||
|
2017
Q4 | $230K | Buy |
|